Nearly half of the participants (49%) had plaque in their arteries. ACTG Read the full article here. Share Related postsSeptember 4, 2024Predicting Incident CVD Risk With High-Sensitivity Cardiac Troponin: Mainstream, Niche, or Neither?Read moreJuly 29, 2024Antiretroviral Abacavir Linked With Cardiovascular Events in REPRIEVE TrialRead more
